531324 — Roselabs Finance Income Statement
0.000.00%
Last trade - 00:00- IN₹305.50m
- IN₹353.67m
- IN₹7.26m
Annual income statement for Roselabs Finance, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.64 | 0 | 1.51 | 11.8 | 7.26 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 0.525 | 0.239 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 29.1 | 4.38 | -19.1 | 13.1 | 10.2 |
| Operating Profit | -27.5 | -4.38 | 20.6 | -1.32 | -2.92 |
| Net Income Before Taxes | -27.5 | -4.38 | 20.6 | -1.32 | -2.92 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -25.7 | -4.37 | 20.2 | -1.32 | -2.92 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -25.7 | -4.37 | 20.2 | -1.32 | -2.92 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.7 | -4.37 | 20.2 | -1.32 | -2.92 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.783 | -0.437 | 0.323 | -0.132 | -0.29 |